The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent Neovascularization

PLoS Pathogens

Volumn 7, Issue 10, 2011, Pages

  Wuest, Todd ^a   Zheng, Min ^a   Efstathiou, Stacey ^b   Halford, William P ^c   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CELL PROTEIN; INFECTED CELL PROTEIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SB 206580; TOLL LIKE RECEPTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ICP4; U 1026; UNCLASSIFIED DRUG; VASCULOTROPIN A; VIRUS PROTEIN; HERPES SIMPLEX VIRUS, TYPE 1 PROTEIN ICP4; IMMEDIATE EARLY PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRAL GENETICS; ANIMAL; C57BL MOUSE; CELL LINE; DNA SEQUENCE; EYE; FLUORESCENCE MICROSCOPY; GENETICS; HERPES SIMPLEX KERATITIS; METABOLISM; METHODOLOGY; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PATHOGENICITY; PATHOLOGY; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

HUMAN HERPESVIRUS 1;

ANIMALS; CELL LINE; EYE; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; KERATITIS, HERPETIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; PLASMIDS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80055092368     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002278     Document Type: Article

References (73)

1. Howard M, Sellors JW, Jang D, Robinson NJ, Fearon M, et al. (2003) Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 41: 84-89.
2. Looker KJ, Garnett GP, (2005) A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect 81: 103-107.
3. Miller CS, Danaher RJ, Jacob RJ, (1998) Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence. Crit Rev Oral Biol Med 9: 541-562.
4. James SH, Kimberlin DW, Whitley RJ, (2009) Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res 83: 210-213.
5. Garcia DD, Shtein RM, Musch DC, Elner VM, (2009) Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure. Cornea 28: 963-965.
6. Chong EM, Dana MR, (2008) Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol 28: 209-222.
7. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, et al. (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113: 1040-1050.
8. Masli S, Turpie B, Streilein JW, (2006) Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells. Int Immunol 18: 689-699.
9. Cueni LN, Detmar M, (2008) The lymphatic system in health and disease. Lymphat Res Biol 6: 109-122.
10. Cursiefen C, Chen L, Dana MR, Streilein JW, (2003) Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22: 273-281.
11. Yamagami S, Dana MR, Tsuru T, (2002) Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea 21: 405-409.
12. Wuest TR, Carr DJ, (2010) VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med 210: 101-115.
13. Harper SJ, Bates DO, (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nature Rev Cancer 8: 880-887.
14. Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, et al. (2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 207: 1441-1440.
15. Gong Y, Koh DR, (2010) Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res 339: 437-48.
16. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, et al. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113: 5650-5659.
17. Spirig R, Djafarzadeh S, Regueira T, Shaw SG, von Garnier C, et al. (2010) Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions. PLoS One 5: e0010983.
18. Martinez-Martin N, Viejo-Borbolla A, (2010) Toll-like receptor-mediated recognition of herpes simplex virus. Front Biosci 2: 718-729.
19. Beutler B, (2004) Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430: 257-263.
20. Berra E, Pages G, Pouyssegur J, (2000) MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 19: 139-145.
21. Botero TM, Son JS, Vodopyanov D, Hasegawa M, Shelburne CE, et al. (2010) MAPK signaling is required for LPS-induced VEGF in pulp stem cells. J Dent Res 89: 264-269.
22. Pagès G, Pouysségur J, (2005) Transcriptional regulation of the vascular endothelial growth factor gene-A concert of activating factors. Cardiovasc Res 65: 564-573.
23. Strowski MZ, Cramer T, Schäfer G, Jüttner S, Walduck A, et al. (2004) Helicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3. FASEB J 18: 221-220.
24. Hargett D, McLean T, Bachenheimer SL, (2005) Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J Virol 79: 8348-8360.
25. Perkins D, Pereira EF, Gober M, Yarowsky PJ, Aurelian L, (2002) The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J Virol 76: 1445-1449.
26. Chen SH, Yao HW, Chen IT, Shieh B, Li C, et al. (2008) Suppression of transcription factor early growth response 1 reduces herpes simplex virus lethality in mice. J Clin Invest 118: 3470-3477.
27. Pavletich NP, Pabo CA, (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 252: 809-817.
28. Nathans D, Christy B, (1989) DNA binding site of the growth factor-inducible protein Zif268. Proc Nat Acad Sci 86: 8737-8741.
29. Raychowdhury R, Schäfer G, Fleming J, Rosewicz S, Wiedenmann B, et al. (2002) Interaction of early growth response protein 1 (Egr-1), specificity protein 1 (Sp1), and cyclic adenosine 3′5′-monophosphate response element binding protein (CREB) at a proximal response element is critical for gastrin-dependent activation of the chromogranin A promoter. Mol Endocrinol 16: 2802-2818.
30. Johnson PA, Everett RD, (1986) DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1. Nucleic Acids Res 14: 3609-3625.
31. Johnson PA, MacLean C, Marsden HS, Dalziel RG, Everett RD, (1986) The product of gene US11 of herpes simplex virus type 1 is expressed as a true late gene. J Gen Virol 67: 871-883.
32. DeLuca NA, Schaffer PA, (1988) Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J Virol 62: 732-743.
33. Malik AK, Martinez R, Muncy L, Carmichael EP, Weller SK, (1992) Genetic analysis of the herpes simplex virus type 1 UL9 gene: isolation of a lacZ insertion mutant and expression in eukaryotic cells. Virology 190: 702-715.
34. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW, (1999) Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med 189: 663-72.
35. Rice SA, Knipe DM, (1990) Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol 64: 1704-1715.
36. Samaniego LA, Webb AL, DeLuca NA, (1995) Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol 69: 5705-5715.
37. Xia K, DeLuca NA, Knipe DM, (1996) Analysis of phosphorylation sites of herpes simplex virus type 1 ICP4. J Virol 70: 1061-1071.
38. Imbalzano AN, Coen DM, DeLuca NA, (1991) Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene. J Virol 65: 565-574.
39. Panagiotidis CA, Lium EK, Silverstein SJ, (1997) Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27. J Virol 71: 1547-1557.
40. Sampath P, Deluca NA, (2008) Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells. J Virol 82: 2339-2349.
41. Hazlett LD, Hendricks RL, (2010) Reviews for immune privilege in the year 2010: immune privilege and infection. Ocul Immunol Inflamm 18: 237-243.
42. Biswas PS, Banerjee K, Kinchington PR, Rouse BT, (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82: 46-54.
43. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, et al. (2003) An angiogenic switch in macrophagesinvolving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163: 711-721.
44. Koff JL, Shao MX, Ueki IF, Nadel JA, (2008) Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 294: L1068-L1075.
45. Georgel P, Jiang Z, Kunz S, Janssen E, Mols J, et al. (2007) Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362: 304-313.
46. Lang KS, Navarini AA, Recher M, Lang PA, Heikenwalder M, et al. (2007) MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus. Eur J Immunol 37: 2434-2440.
47. Yang P, An H, Liu X, Wen M, Zheng Y, et al. (2010) The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 11: 487-494.
48. Furr SR, Moerdyk-Schauwecker M, Grdzelishvili VZ, Marriott I, (2010) RIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes. Glia 58: 1620-1629.
49. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, et al. (2007) TLR3 deficiencyin patients with herpes simplex encephalitis. Science 317: 1522-1527.
50. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, et al. (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597.
51. Perry AK, Chen G, Zheng D, Tang H, Cheng G, (2005) The host type I interferon response to viral and bacterial infections. Cell Res 15: 407-22.
52. Brennan K, Bowie AG, (2010) Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 13: 503-507.
53. Mimura K, Kono K, Takahashi A, Kawaguchi Y, Fujii H, (2007) Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol Immunother 56: 761-770.
54. Yu CQ, Zhang M, Matis KI, Kim C, Rosenblatt MI, (2008) Vascular endothelial growth factor mediates corneal nerve repair. Invest Ophthalmol Vis Sci 49: 3870-3878.
55. Smith CA, Schaffer PA, (1987) Intertypic recombinants of herpes simplex virus types 1 and 2 infected-cell polypeptide 4. Virology 160: 176-182.
56. Iwahori S, Shirata N, Kawaguchi Y, Weller SK, Sato Y, et al. (2007) Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein. J Virol 81: 9653-9664.
57. Kim DB, DeLuca NA, (2002) Phosphorylation of transcription factor Sp1 during herpes simplex virus type 1 infection. J Virol 76: 6473-6479.
58. Imbalzano AA, Shepard AA, DeLuca NA, (1990) Functional relevance of specific interactions between herpes simplex virus type 1 ICP4 and sequences from the promoter-regulatory domain of the viral thymidine kinase gene. J Virol 64: 2620-2631.
59. Qiu Y, Hoareau-Aveilla C, Oltean S, Harper SJ, Bates DO, (2009) The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans 37: 1210-1213.
60. Smith RW, Malik P, Clements JB, (2005) The herpes simplex virus ICP27 protein: a multifunctional post-transcriptional regulator of gene expression. Biochem Soc Trans 33: 499-501.
61. Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA, (2009) Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 69: 349-357.
62. Nishimoto F, Sakata M, Minekawa R, Okamoto Y, Miyake A, et al. (2009) Metal transcription factor-1 is involved in hypoxia-dependent regulation of placenta growth factor in trophoblast-derived cells. Endocrinology 150: 1801-1808.
63. Wuest T, Farber J, Luster A, Carr DJ, (2006) CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol 243: 83-89.
64. Wuest TR, Carr DJ, (2008) Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J Immunol 181: 7985-7993.
65. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, et al. (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725.
66. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, et al. (1999) VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159.
67. DeLuca NA, Schaffer PA, (1987) Activities of herpes simplex virus type 1 ICP4 genes specifying nonsense peptides. Nucleic Acids Res 15: 4491-4511.
68. Halford WP, Kemp CD, Isler JA, Davido DJ, Schaffer PA, (2001) ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol 75: 6144-6153.
69. Proença JT, Coleman HM, Connor V, Winton DJ, Efstathiou S, (2008) A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurons. J Gen Virol 89: 2965-2974.
70. Von Marschall Z, Cramer T, Höcker M, Finkenzeller G, Wiedenmann B, et al. (2001) Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut 48: 87-96.
71. Härle P, Cull V, Agbaga MP, Silverman R, Williams BR, et al. (2002) Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J Virol 76: 6558-6567.
72. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, et al. (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62: 1315-1320.
73. Funaki H, Nishimura G, Harada S, Ninomiya I, Terada I, et al. (2003) Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. Oncology 64: 416-422.